Concepedia

Publication | Closed Access

Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.

183

Citations

36

References

2003

Year

Abstract

Our results indicate that 18F-FDG PET is a useful diagnostic modality for advanced, metastatic, or recurrent gastric cancer but not for detecting bone metastases, peritonitis, or pleuritis carcinomatoses. 18F-FDG uptake by gastric cancers is relatively high but does not parallel histopathologic features of malignancy.

References

YearCitations

Page 1